About this trial
Automated insulin delivery systems, also known as closed-loop systems, have shown to improve TIR, TAR, and TBR compared with insulin pump and CGM systems that cannot automatically dose insulin. Only few studies have described long-term use of AID systems over several years. Real-world studies suggest that the beneficial effects of AID systems on glycemic outcomes are sustained over time; however, a modest increase in body weight has been observed in some users, raising concerns about the metabolic trade-offs of improved glycemia. We aim to explore wether the improvements in glycemic outcomes and treatment satisfaction achieved with AID systems remain stable over multiple years, and secondly, if long-term treatment with AID systems may be associated with an increase in body weight.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Previous participation in the Steno780G study
Disqualifiers
Lack of compliance with key study procedures at the discretion of the investigator.
Trial population
Study participants who have previously participated in the Steno780G study will be invited for a follow-up visit
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
780G AID pump
DeviceLong term follow-up
Treatment groups
Trial outcomes
Primary outcomes
Time in range
Secondary outcomes
Time above and below range
HbA1c
Body weight
Mean sensor glucose
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: